Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Mutation Research|September 3, 1998
Modulation of O6-alkylating agent induced clastogenicity by enhanced DNA repair capacity of bone marrow cellsN Chinnasamy, L J Fairbairn, J Laher, et al.
Cancer Gene Therapy|April 19, 2000
Enhancing hemopoietic drug resistance: a rationale for reconsidering the clinical use of mitozolomideL J Fairbairn, N Chinnasamy, L S Lashford, et al.
Experimental Hematology|February 1, 1995
O6-benzylguanine increases the sensitivity of human primary bone marrow cells to the cytotoxic effects of temozolomideL J Fairbairn, A J Watson, J A Rafferty, et al.
Expert Reviews in Molecular Medicine|February 28, 2004
New perspectives for cancer chemotherapy by genetic protection of haematopoietic cellsC Baum, L J Fairbairn, M Hildinger, et al.
Molecular Carcinogenesis|September 1, 1994
bcl-2 delay of alkylating agent-induced apoptotic death in a murine hemopoietic stem cell lineL J Fairbairn, G J Cowling, T M Dexter, et al.
Pageof 4